非骨水泥初次全髋关节置换系统的临床结局与中期生存率
该研究回顾性分析了一个前瞻性数据库,评估单一厂商非骨水泥股骨柄与髋臼杯全髋关节置换系统的功能结局、翻修数据与生存率。共纳入1942例初次全髋关节置换,随访10年无髋臼失败病例;全因翻修10年生存率为97.0%(95%CI 96.0-98.0),排除感染后提高至98.7%(95%CI 98.1-99.4)。
要点
- 全因翻修10年生存率97.0%(95%CI 96.0-98.0)。
- 排除感染后10年生存率98.7%(95%CI 98.1-99.4)。
- 10年随访无髋臼失败病例,功能评分显著改善。
核心结论
- 该非骨水泥压配髋臼联合三锥度股骨柄的全髋关节置换系统是优秀选择,其2、5、10年生存率处于全球报道的最佳水平之列。
研究设计与样本
- 回顾性分析前瞻性生成数据库,评估单一厂商股骨柄与髋臼杯行全髋关节置换的结局。
- 共植入1942例初次全髋关节置换,涉及1672例患者。
主要发现
- 共发生57例翻修,10年随访无髋臼失败病例。
- 所有功能结局评分在全髋关节置换后均显示显著改善。
- 全因翻修Kaplan-Meier生存率:2年97.6%(95%CI 96.9-98.3),5年97.3%(95%CI 96.5-98.1),10年97.0%(95%CI 96.0-98.0)。
- 排除感染后生存率:2年99.2%(95%CI 98.8-99.6),5年98.9%(95%CI 98.5-99.4),10年98.7%(95%CI 98.1-99.4)。
临床怎么用
- 对于适合非骨水泥全髋关节置换的患者,该三锥度股骨柄联合压配髋臼系统可考虑作为优选方案。
- 术后随访中需关注感染相关翻修风险,排除感染后假体生存率更高。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The rise in total hip arthroplasty (THA) has led to a concomitant increase in revision THAs. Tracking implant performance therefore remains a significant element of scientific inquiry to garner and maintain public trust in this procedure. There are few available reports of outcomes of a single manufacturer's total hip system outside registry data. METHODS: We performed a retrospective review of a prospectively generated database to evaluate outcomes of a single manufacturer's femoral stem and acetabular shell for THA. We report the functional outcomes, revision data, and survivorship for this total hip system. RESULTS: A total of 1942 primary THAs were implanted into 1672 patients. There were of 57 revisions. There were no cases of acetabular failure at 10-year follow-up. All functional outcome scores demonstrated significant improvements following THA. Kaplan-Meier survival analysis for all-cause revisions demonstrated 2-year implant survival of 97.6% (95% confidence interval [CI], 96.9-98.3), 5-year implant survival of 97.3% (95% CI, 96.5-98.1), and 10-year implant survival of 97.0% (95% CI, 96.0-98.0). When infection was excluded, implant survivorship improved to 99.2% (95% CI, 98.8-99.6) at 2 years, 98.9% (95% CI, 98.5-99.4) at 5 years, and 98.7% (95% CI, 98.1-99.4) at 10 years. CONCLUSION: This THA implant system comprising an uncemented press-fit acetabulum used alongside a triple-tapered femoral stem is an excellent option for THA. Implant survivorship at 2, 5, and 10 years is among the best reported for any total hip system in the world.
引用
- Chaudhry H, MacDonald SJ, Howard JL, et al. Clinical Outcomes and Midterm Survivorship of an Uncemented Primary Total Hip Arthroplasty System. J Arthroplasty. 2020. PMID: 32088053. doi:10.1016/j.arth.2020.01.063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。